Alfresa Holdings Corporation (ALFRY)

OTCMKTS · Delayed Price · Currency is USD

13.55

0.00 (0.00%)

Sep 3, 2026, 4:00 PM EST

Market Cap	2.60B -7.0%
Revenue (ttm)	19.29B +4.6%
Net Income	241.27M +40.3%
EPS	1.33 +42.8%
Shares Out	n/a
PE Ratio	10.79
Forward PE	n/a
Dividend	0.44 (3.23%)
Ex-Dividend Date	Sep 29, 2026

Volume	100
Open	13.55
Previous Close	13.55
Day's Range	13.55 - 13.55
52-Week Range	11.39 - 16.81
Beta	-0.15
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 9, 2026

About Alfresa Holdings

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. The company operates through Wholesale of Prescription Drugs and Related Products, Wholesale of Self-Medication Products, Manufacturing of Pharmaceuticals and Related Products, and Pharmacy and Related Businesses segments. It is also involved in the operation of dispensing pharmacies and conducting related businesses; ethic... [Read more]

Industry Medical Distribution

Sector Healthcare

Founded 2003

Employees 12,525

Stock Exchange OTCMKTS

Ticker Symbol ALFRY

Financial Performance

In fiscal year 2026, Alfresa Holdings's revenue was 3.10 trillion, an increase of 4.83% compared to the previous year's 2.96 trillion. Earnings were 41.75 billion, an increase of 52.42%.

Financial numbers in JPY Financial Statements